BIXT
BIOXYTRAN, INC
Key Financials
Revenue
$191077
↓ 22.5%
Operating Income
$-2223068
↑ 41.8%
Net Income
$-2366681
↑ 44.7%
Total Assets
$138694.00
↑ 0.8%
Total Liabilities
$1.9M
↓ 40.6%
EPS (Diluted)
$-0.02
↑ 33.3%
Cash & Equivalents
$11092.00
↑ 218.6%
Gross Profit
$87098
↓ 42.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BIXT |
| Company Name | BIOXYTRAN, INC |
| CIK | 1445815 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 617-494-1199 |